Portola Pharma (PTLA) Tops Q2 EPS by 18c

August 9, 2016 4:27 PM EDT
Get Alerts PTLA Hot Sheet
Trade PTLA Now!
Join SI Premium – FREE

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Portola Pharma (NASDAQ: PTLA) reported Q2 EPS of ($1.02), $0.18 better than the analyst estimate of ($1.20). Revenue for the quarter came in at $4.23 million versus the consensus estimate of $4.38 million.

For earnings history and earnings-related data on Portola Pharma (PTLA) click here.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment